Ainsworth S.
25
Coauthors
4
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Inmunología | 6 |
| Biotecnología | 2 |
| Infección | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Microorganismos, hongos y algas | 3 |
| Enfermedades | 2 |
| Farmacología y terapéutica | 2 |
| Medicina y salud | 1 |
| Fisiología y materias afines | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 4 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Stefanie K. Menzies | 4 |
| Harrison R.A. | 3 |
| Casewell N.R. | 3 |
| Alsolaiss J. | 2 |
| Dawson C.A. | 2 |
| Wilkinson M.C. | 2 |
| Edge R.J. | 2 |
| Hall S.R. | 2 |
| Crittenden E. | 2 |
| Pleass R.J. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19
OtherAbstract: Published data on the first 5,000 coronavirus patients to receive plasma shows promise in the UnitedPalabras claves:Antibodies, covid19, hyper-immune sera, Plasma, therapyAutores:Ainsworth S., Pleass R.J., Stefanie K. MenziesFuentes:scopusAn analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management
ArticleAbstract: Background The World Health Organization’s strategy to halve snakebite mortality and morbidity by 20Palabras claves:Autores:Ainsworth S., Casewell N.R., Harrison R.A., Stefanie K. MenziesFuentes:scopusVirus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
ArticleAbstract: Antivenom is currently the first-choice treatment for snakebite envenoming. However, only a low propPalabras claves:Autores:Ainsworth S., Alsolaiss J., Casewell N.R., Crittenden E., Dawson C.A., Edge R.J., Hall S.R., Harrison R.A., Stefanie K. Menzies, Wilkinson M.C.Fuentes:scopusExploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
ArticleAbstract: Snakebite is a neglected tropical disease that causes high rates of global mortality and morbidity.Palabras claves:antivenom, immunogen, neglected tropical diseases, polyclonal antibodies, recombinant expression, serine proteases, snake venom toxin, snakebiteAutores:Ainsworth S., Alomran N., Alsolaiss J., Blundell P., Casewell N.R., Crittenden E., Dawson C.A., Edge R.J., Hall S.R., Harrison R.A., Stefanie K. Menzies, Wilkinson M.C.Fuentes:scopus